December 2008 Issue of MMM
I have a confession to make about this year's MM&M Awards evening and it has nothing to do with any adverse events at the afterglow ...
More than 750 healthcare marketing and communications execs flocked to the MM&M Awards gala presentation dinner at New York's Tavern on the Green on October ...
The Democrats are mixing up some strong medicine for the pharma industry. Matthew Arnold performs a risk-benefit analysis
MM&M takes a detailed look at key products in the pipeline, highlighting the most promising with insights and ratings from top analysts, to provide an ...
In today's market, with a dwindling pharma pipeline, there are fewer launches to pitch for and more competition among healthcare agencies for those coveted launches. ...
As director of regulatory advertising, promotion and global labeling for Shire Human Genetics Therapies (HGT), Cynthia Phillips supports the marketing team to ensure compliance for ...
It's that time of year again—time to organize our thoughts for the new year and get ready as healthcare marketing researchers to make the biggest ...
I have written about the cholesterol-lowering statin drugs in this space before. All my readers know I am a big fan of these drugs, prescribe ...
Merck's announcement in October to reorganize its business—and shed 6,800 employees in the process—caps a year of heavy job losses across the industry.
Med Ed Report
A new training effort aims to help med ed faculty distinguish between certified and promotional CME, while separately, an ad campaign running in journals promotes ...
GlaxoSmithKline plans to disclose payments to US physicians and impose a cap of $150,000 per year, per doctor, but details of the disclosure scheme are ...
In the battle for unique visitors, Waterfront Media's Everyday Health has surpassed WebMD to lead the online consumer health space.
Lippincott Williams & Wilkins (LWW), a division of Wolters Kluwer Health, has signed an agreement with the American Association of Neuroscience Nurses's official journal.
When it comes to online activity, everyone has short attention span. How do websites and other applications draw and hold consumers for long-form media like ...
San Mateo, CA-based Epocrates announced that hundreds of thousands of healthcare professionals and consumers, including more than 50,000 US physicians, have downloaded its drug and ...
The traditional sales force model is no longer effective as doctors are no longer the key prescribing decision makers, according to the results of a ...
The results of a recent study revealed that doctors want more clinical information from drug reps but want to spend less time interacting with them.
The FDA's Division of Drug Marketing, Advertising and Communications (DDMAC) issued an untitled letter on a patient brochure for Amgen's Sensipar.
Attorneys at the Washington law firm of McDermott Will & Emery advised in October that companies wishing to avoid FDA challenges to drug ads and ...
It seems like there are thousands of web communities online these days.
Waterfront Media's Everyday Health Network announced that it will provide content to Yahoo! Health under a new partnership.
Sermo has teamed up with Bloomberg to develop a groundbreaking forum that gives investors instant access to medical information and the opinions of its community ...
Nearly five years after the human genome was decoded, the age of genetics is finally upon us; "personalized medicine" has arrived.
Medical device and surgical manufacturer Covidien has launched a website to educate patients and physicians on the benefits of bariatric surgery as a treatment for ...
During a period of economic instability, consumers tend to focus on day-to-day life, rather than considering the long view.
IMS Health is forecasting a 4.5% to 5.5% growth in the global pharmaceutical market during 2009, with dollar amounts exceeding $820 billion.
Rapidly changing demographics are affecting the complexion of America, and many groups aren't adequately targeted for healthcare products and services.
As the Obama transition team focuses on the nation's highest priorities, don't think for a moment that drug marketing issues will get a pass come ...
The FDA's director of drug evaluation and research, Janet Woodcock, denied in October that an increased focus on drug safety in recent years, fueled by ...
Ortho-McNeil/Janssen said a Public Citizen petition to the FDA calling for removal of the Ortho Evra contraceptive patch from the market for safety reasons "presents ...
The American Association for Justice said federal agency documents it obtained through Freedom of Information Act requests show that former FDA chief counsel Daniel Troy ...
Two consumer-directed pharmacy printouts and a professionally directed labeling piece for Boehringer-Ingelheim's Mirapex were considered misleading, according to a warning letter from FDA's DDMAC.
No, not that kind of rehab. On October 4 I had a stroke.
- Five things for pharma marketers to know: Wednesday, March 22, 2017
- Five things for pharma marketers to know: Monday, March 20, 2017
- Novartis aims to bring first oral asthma drug to market in two decades
- Drugmakers target severe asthma patients with biologics, but payers raise pricing issue
- What five different pharma marketing careers look like
- 2017 Healthcare Marketers Trend Report: All the data in one place
- Infographic: What's next for the point of care market
- Drugmakers again boost DTC spending, to $5.6 billion in 2016
- Digital IDs become focus as drugmakers seek to track doctors' behavior online
- Some CME experts remain skeptical when it comes to social media
- Five things for pharma marketers to know: Monday, March 27, 2017
- P&G exec who led Always #LikeAGirl campaign moves to comms leadership role at Novartis
- Pro ad report: All the data on journal spending in 2016
- SPONSORED: Video Interview with Tim Armand, Health Union
- Five things for pharma marketers to know: Friday, March 24, 2017